Al-Modawat Specialized Medical Co.’s net profit increased by more than threefold to SAR 19 million in 2025, from SAR 6.1 million a year earlier.
| Item | 2024 | 2025 | Change |
|---|---|---|---|
| Revenues | 75.49 | 121.82 | 61.4 % |
| Gross Income | 31.01 | 53.01 | 71.0 % |
| Operating Income | 7.56 | 22.04 | 191.4 % |
| Net Income | 6.07 | 18.98 | 212.4 % |
| Average Shares | 71.25 | 71.25 | - |
| Earnings Per Share before unusual items (Riyals) | 0.09 | 0.27 | 212.4 % |
| EPS (Riyal) | 0.09 | 0.27 | 212.4 % |
The profit growth was driven by a 61% year-on-year (YoY) rise in revenue, aided by the partial operation of previously announced expansions and service enhancements.
Moreover, an increase in expenses was controlled by Al-Modawat at 48% only, reflecting improved operational efficiency.
| Item | H2 2024 | H2 2025 | Change |
|---|---|---|---|
| Revenues | 38.20 | 66.60 | 74.3 % |
| Gross Income | 13.68 | 27.31 | 99.6 % |
| Operating Income | 3.78 | 10.82 | 186.5 % |
| Net Income | 2.91 | 8.63 | 196.2 % |
| Average Shares | 71.25 | 71.25 | - |
| Earnings Per Share before unusual items (Riyal) | 0.04 | 0.12 | 196.2 % |
| EPS (Riyal) | 0.04 | 0.12 | 196.2 % |
| Item | H1 2025 | H2 2025 | Change |
|---|---|---|---|
| Revenues | 55.22 | 66.60 | 20.6 % |
| Gross Income | 25.70 | 27.31 | 6.3 % |
| Operating Income | 11.22 | 10.82 | (3.6 %) |
| Net Income | 10.35 | 8.63 | (16.7 %) |
| Average Shares | 71.25 | 71.25 | - |
| Earnings Per Share before unusual items (Riyal) | 0.15 | 0.12 | (16.7 %) |
| EPS (Riyal) | 0.15 | 0.12 | (16.7 %) |
H2 2025 profit surged 196% to SAR 8.6 million, compared to SAR 2.91 million in the prior-year period.
However, net profit dropped by 16.7% from SAR 10.35 million in H1 2025.
Total shareholders’ equity (no minority interest) amounted to SAR 88.25 million as of Dec. 31, 2025, compared to SAR 77.12 million in a year earlier period.
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: